Agreed. We are definitely not getting up to date progress notes on K. When it comes to K... info seems to be distributed in conjuction with conferences... ASCO, R&R... the best tidbits are being saved for those it would appear... and the November conference looks like it is all about Brilacidin... I am confident they know significantly more from 50 mg dose & soon from 75 mg dose... would love a PR with details, but not holding my breath...
that's right. cohort 4 up and running jun 3. 4-1/2 months. that means 4 serum markers and 2 mri's that leo and dr menon know about. cohort 5 took a lot of "winding down) but no dlt's and leo was emailing dose escalation for cohort 6 probability. means he knew 5's serum markers were good.
what we don't know is why cohort 4 & 5 in combination had 8 participants instead of six. reason could be benign.
stock will move if results for cohort 4 & 5 are are released. imo. that kind of info only gets published when there is an asco or R & R. gov
ps would help if we knew if any of these early terminal patiens are still with us. i am partial to the 80 year old with uterine cancer 103.
News 
Market Data 
Discover 
AI
